Press "Enter" to skip to content

HHS Ousts Peter Marks, Sending Vaccine Stocks Tumbling and Biopharma Lamenting Loss of ‘Ally’ at FDA

The reaction to the forced resignation of Peter Marks, M.D., Ph.D., director of the FDA’s agency responsible for authorizing vaccines, by markets and the pharmaceutical industry is indicative of the influence Big Pharma had over the FDA, said Brian Hooker, Ph.D., Children’s Health Defense chief scientific officer.

Pharma stocks tumbled today after Peter Marks, M.D., Ph.D., director of the agency within the U.S. Food and Drug Administration (FDA) responsible for authorizing vaccines, resigned under pressure from his new boss, Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.

“If Peter Marks does not want to get behind restoring science to its golden standard and promoting radical transparency, then he has no place at FDA under the strong leadership of Secretary Kennedy,” an HHS official said in a statement.

Shares of Moderna, BioNTech, Novavax and Pfizer declined 11%, 7%, 6% and 2%, respectively, on the news, Fast Company reported. STAT News reported that Marks’ departure “is a worst-case scenario realized” for investors and “a biopharma industry that saw him as an ally.”

Read Full Article Here…(childrenshealthdefense.org)


Home | Caravan to Midnight (zutalk.com)

Live Stream + Chat (zutalk.com)

We Need Your Help to Keep Caravan To Midnight Going,

Please Consider Donating to Help Keep Independent Media Independent

Breaking News: